Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancersMuhammad Alaa Eldeen, B R Kim, Ahmed Refaat et al.|BMC Cancer|2026Cited by 0
Pan-Cancer Multi-Omics and Structure-Guided Drug Discovery Identify TUBG1 as a Clinically and Immunologically Relevant TargetMuhammad Alaa Eldeen, Bonglee Kim, Najiah M. Alyamani et al.|Journal of Computational Biophysics and Chemistry|2026Cited by 0